US2022296640A1PendingUtilityA1
Biomarkers for joint ailments and uses thereof
Est. expiryMar 12, 2039(~12.7 yrs left)· nominal 20-yr term from priority
A61K 33/34G01N 2800/10A61K 31/198A61K 33/32G01N 33/6893G01N 2333/575A61P 19/02A61K 33/30G01N 2333/78
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to biomarkers that are associated with joint disorders, and methods of using the biomarkers diagnose joint ailments, monitor the progression of joint ailments, determine when treatments is indicated, and monitor the efficiency of treatment. Also provided are methods for treating joint ailments, which comprise administering chelated trace minerals to animals diagnosed with or predisposed to having joint ailments.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for treating or reducing the severity of lameness due to inflammation in a pig, the method comprising:
(a) determining the level of a ratio of two biomarkers in a blood sample from the pig, wherein the ratio of two biomarkers is selected from OC/CTX1, P2CP/C2C, and P2CP/CTX2; (b) comparing the level of the ratio of the pig to a non-lame pig having a gait score of about 0 on a 5 point scale to determine whether the pig is lame, wherein the pig is lame if the level of one or more of the ratios is decreased compared to the non-lame pig; (c) administering an effective amount of metal chelate to the pig if the pig is determined to be lame, wherein the metal chelate results in the at least one ratio increasing and a reduction of the lameness.
2 . The method of claim 1 , wherein in step (b) the level of a single biomarker selected from C2C, CTX1, CTX2, OC and P2CP may be determined.
3 . The method of claim 1 , wherein step (b) comprises an antibody-based detection method.
4 . The method of claim 1 , wherein the metal chelate comprises at least one metal ion and at least one ligand, wherein the at least one ligand is an amino acid, hydroxy acid, organic acid, sugar alcohol, protein, protein hydrolysate, polysaccharide, or polynucleic acid.
5 . The method of claim 4 , wherein the at least one metal ion is calcium, chromium, cobalt, copper, iron, magnesium, manganese, nickel, potassium, sodium, zinc, or combination thereof.
6 . The method of claim 4 , wherein the at least one ligand is a compound of Formula (I):
wherein:
R 1 is methyl or ethyl; and
n is 1 or 2.
7 . The method of claim 6 , wherein R 1 is methyl and n is 2.
8 . The method of claim 7 , wherein the at least one metal ion is copper, manganese, zinc, or combination thereof.
9 . The method of claim 1 , wherein the pig is at risk for developing lameness due to inflammation.
10 . The method of claim 1 , wherein the pig is lame and has a gait score of about 2 or more on a 5 point scale.
11 . The method of claim 1 , wherein the metal chelate reduces symptoms of lameness compared to administering an inorganic mineral to a comparable pig afflicted with lameness due to inflammation.
12 . A method for treating or preventing lameness due to inflammation in a pig, the method comprising administering a metal chelate to the pig, wherein the metal chelate reduces symptoms of lameness compared to administering an inorganic mineral to a comparable pig afflicted with lameness due to inflammation.
13 . The method of claim 12 , wherein the metal chelate comprises at least one metal ion and at least one ligand, wherein the at least one ligand is an amino acid, hydroxy acid, organic acid, sugar alcohol, protein, protein hydrolysate, polysaccharide, or polynucleic acid.
14 . The method of claim 13 , wherein the at least one metal ion is calcium, chromium, cobalt, copper, iron, magnesium, manganese, nickel, potassium, sodium, zinc, or combination thereof.
15 . The method of claim 13 , wherein the at least one ligand is a compound of Formula (I):
wherein:
R 1 is methyl or ethyl; and
n is 1 or 2.
16 . The method of claim 15 , wherein R 1 is methyl and n is 2.
17 . The method of claim 15 , wherein the at least one metal ion is copper, manganese, zinc, or combination thereof.
18 . The method of claim 12 , wherein the pig is at risk for developing lameness due to inflammation.
19 . The method of claim 12 , wherein the pig has been diagnosed as lame.
20 . The method of claim 19 , wherein the pig has a gait score of about 2 or more on a 5 point scale.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.